retatrutide semaglutide side effects vs Semaglutide: Triple vs Single Agonist Comparison - Which Is Better? Retatrutide vs Semaglutide: Speed of

A meta-analysis of 15 randomized controlled trials involving 14,471 patients found no statistically significant increase in UTI risk among tirzepatide users compared to placebo at any dose (5mg, 10mg, or 15mg)

PlexusDx uses this data to guide your dosing decisions throughout your treatment journey

Much like managing insulin therapy from a Read More GLP-1 Therapy Discontinuation: How to Identify Patients at Risk and Prevent Drop-Off May 5, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Type 2 Diabetes, Type 2 Diabetes 993 views Discontinuation of GLP-1 therapy is becoming a growing concern in diabetes care, even though these treatments show strong clinical benefits

Internal links: Medical Weight Loss, Peptides, Functional Medicine

Archived from the original on June 12, 2026